Literature review · Ageing & cellular health / Immune & inflammation

Glutathione

Glutathione is an endogenous tripeptide involved in cellular redox biology. Selected oral human trials produced differing biomarker results, and neither trial validates a nasal or vial product.

By HeartPep · Reviewed · 3 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

A four-week trial did not change measured glutathione or oxidative-stress markers. A six-month study reported increased stores in several compartments. Different durations, methods and populations limit direct comparison; neither establishes lifespan extension or reduced infections.

Identity & scope

The cited supplementation studies concern glutathione, commonly abbreviated GSH. Its biological presence in the body and its antioxidant role do not by themselves establish benefits from an externally supplied formulation.

Catalogue labels covered: Glutathione.

What the research shows

  • Allen and Bradley found no significant effect on the selected oxidative-stress or glutathione-status markers.
  • Richie and colleagues reported increased compartment glutathione stores and selected secondary immune-marker changes after longer supplementation.

Critical interpretation

A disagreement worth preserving

The short and longer supplementation trials do not support a single universal claim that oral glutathione always works or never works. Their durations, assays and measured compartments differ. Our interpretation is that the apparent disagreement is a research question about exposure and measurement, not a reason to discard the negative trial. A stronger synthesis would compare prespecified between-group effects and uncertainty for the same compartment and time point before considering pooled estimates. [1] [2]

Formulation comparisons require the actual contrast

The 2026 pilot adds a pharmacokinetic comparison, not evidence of fewer illnesses or longer life. Because formulations and administered amounts differ, a reader should distinguish the observed comparison from a dose-normalised calculation. Neither should be translated directly into a nasal or vial claim. The study is also small and commercially connected, making independent replication with preregistered analyses particularly useful. [3]

Markers are a starting point

A clinically informative programme would connect reproducible exposure with a specific functional outcome and a meaningful safety window. Redox markers and selected immune assays can help test mechanisms, but are not interchangeable with disease prevention or patient wellbeing. [1] [2] [3]

Limitations & uncertainties

  • The evidence described here involves oral study formulations, not HeartPep nasal or vial products.
  • A biomarker change is not automatically a functional or clinical benefit.
  • Small trials and selected immune-marker subsets do not establish broad immune protection or long-term clinical safety.

Open research questions

  • Which formulation and exposure explain apparently different biomarker results?
  • Do reproducible changes translate into prespecified patient-important outcomes?

Selected papers & source records

Download bibliography
Human studyNamed compoundAbstract / record checked

1. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers (opens in a new tab)

Allen J, Bradley RD (2011). Journal of Alternative and Complementary Medicine. DOI: 10.1089/acm.2010.0716 (opens in a new tab) · PMID 21875351

Design & population
Four-week randomised double-blind placebo-controlled study in 40 healthy adults; 39 completed per protocol.
What the study found
No significant between-group changes in urinary oxidative-stress biomarkers or measured glutathione status.
Limits on interpretation
Short study in healthy volunteers. It does not establish the result for other populations, durations or delivery formats.
Human studyNamed compoundAbstract / record checked

2. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione (opens in a new tab)

Richie JP Jr, Nichenametla S, Neidig W, et al. (2015). European Journal of Nutrition. DOI: 10.1007/s00394-014-0706-z (opens in a new tab) · PMID 24791752

Design & population
Six-month randomised double-blind placebo-controlled oral-supplement study in 54 non-smoking adults.
What the study found
Reported higher glutathione stores in several compartments and changes in selected redox and immune markers.
Limits on interpretation
Marker-focused and small; immune measures were assessed in a subset. It did not establish general disease prevention or catalogue-format efficacy.
Human studyNamed compoundAbstract / record checked

3. A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial (opens in a new tab)

Solnier J, et al. (2026). Antioxidants. DOI: 10.3390/antiox15030354 (opens in a new tab) · PMID 41897500

Design & population
Small randomised double-blind crossover oral-formulation comparison in 14 adults, followed by a single-arm short safety follow-up.
What the study found
Reported formulation-dependent differences in baseline-adjusted whole-blood glutathione exposure.
Limits on interpretation
Pharmacokinetic pilot, not clinical efficacy. Administered amounts differed; dose-normalised analyses require careful interpretation. Relevant commercial and patent interests are disclosed.

Search & review scope

Targeted primary-record review using PubMed, PMC and publisher records, starting with existing HeartPep references and selected additional searches.. Checked 9 November 2026.

Two selected oral biomarker trials and a 2026 formulation-dependent pharmacokinetic pilot. Accessible records and linked notices checked; direct PMC full-text access to some papers was blocked, so those records remain abstract-led.

Selected narrative evidence review, not a systematic search or meta-analysis. Abstract-led unless an individual record is marked full-text. No claim that all studies, registries or unpublished results were searched. Linked notices and targeted correction/retraction searches were checked where accessible. This is not a complete publication-status or raw-data audit; missing search results do not certify that a paper has no updates.

Recorded search terms
  • 24791752 glutathione randomized controlled trial
  • site:pubmed.ncbi.nlm.nih.gov oral glutathione 2011 randomized trial oxidative stress Allen Bradley
  • "21875351" "10." Allen Bradley
  • "41897500" glutathione crossover 2026
  • "10.1007/s00394-014-0706-z" correction retraction
  • "10.1089/acm.2010.0716" correction retraction

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. Glutathione: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/glutathione.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes